About Imricor
Imricor is a company based in Burnsville (United States) founded in 2006.. Imricor has raised $9.1 million across 11 funding rounds from investors including HHS. Imricor offers products and services including Vision-MR Ablation Catheter, Advantage-MR EP Recorder / Stimulator, and Additional Products. Imricor operates in a competitive market with competitors including Endosense, Ablation Frontiers, DC Medical, AblaCor and Aqua Heart, among others.
- Headquarter Burnsville, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Imricor Medical Systems Inc.
-
Annual Revenue
$898.17 K (USD)56.84as on Dec 31, 2024
-
Net Profit
$-27.89 M (USD)-32.06as on Dec 31, 2024
-
EBITDA
$-14.44 M (USD)3.26as on Dec 31, 2024
-
Total Equity Funding
$9.1 M (USD)
in 11 rounds
-
Latest Funding Round
$613.08 K (USD), Post-IPO
Sep 11, 2019
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Imricor
Imricor is a publicly listed company on the ASX with ticker symbol IMR in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Imricor
Imricor offers a comprehensive portfolio of products and services, including Vision-MR Ablation Catheter, Advantage-MR EP Recorder / Stimulator, and Additional Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Catheter for cardiac ablation in iCMR procedures.
System for electrophysiology recording and stimulation in iCMR.
Supplementary items for cardiac ablation support.
Unlock access to complete
Unlock access to complete
Funding Insights of Imricor
Imricor has successfully raised a total of $9.1M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $613.08 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $613,079
-
First Round
First Round
(01 Jul 2006)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Post-IPO - Imricor | Valuation |
investors |
|
| Apr, 2018 | Amount | Debt – Conventional - Imricor | Valuation |
investors |
|
| Sep, 2017 | Amount | Series A - Imricor | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Imricor
Imricor has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Imricor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Imricor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Imricor Comparisons
Competitors of Imricor
Imricor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endosense, Ablation Frontiers, DC Medical, AblaCor and Aqua Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Catheter ablation technology for treating cardiac arrhythmias is developed.
|
|
| domain | founded_year | HQ Location |
Cardiac ablation devices are developed for arrhythmia treatment.
|
|
| domain | founded_year | HQ Location |
Develops innovative biomimetic mesh and premature birth diagnostic kits for medical applications.
|
|
| domain | founded_year | HQ Location |
Develops ablation catheter technology for treating atrial fibrillation.
|
|
| domain | founded_year | HQ Location |
Develops single-shot therapy for atrial fibrillation using advanced medical technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Imricor
Frequently Asked Questions about Imricor
When was Imricor founded?
Imricor was founded in 2006.
Where is Imricor located?
Imricor is headquartered in Burnsville, United States. It is registered at Burnsville, Minnesota, United States.
Is Imricor a funded company?
Imricor is a funded company, having raised a total of $9.1M across 11 funding rounds to date. The company's 1st funding round was a Series A of $1.58M, raised on Jul 01, 2006.
What is the annual revenue of Imricor?
Annual revenue of Imricor is $898.17K as on Dec 31, 2024.
What does Imricor do?
Developer of magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias. The company offers Vision MR EP Ablation Catheter that looks and performs as a conventional ablation catheter; and Horizon MR EP Recording System, which performs the recording and pacing function of conventional recording and pacing systems for use with MRI. Its products allow electrophysiologists to perform cardiac electrophysiology procedures in the MRI lab to image a patients heart.
Who are the top competitors of Imricor?
Imricor's top competitors include Endosense, Ablation Frontiers and DC Medical.
What products or services does Imricor offer?
Imricor offers Vision-MR Ablation Catheter, Advantage-MR EP Recorder / Stimulator, and Additional Products.
Is Imricor publicly traded?
Yes, Imricor is publicly traded on ASX under the ticker symbol IMR.
Who are Imricor's investors?
Imricor has 1 investor. Key investors include HHS.
What is Imricor's ticker symbol?
The ticker symbol of Imricor is IMR on ASX.